Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach

Abstract Purpose of Review A modified Delphi process was undertaken to provide a US expert-led consensus to guide clinical action on short-acting beta 2 -agonist (SABA) use. This comprised an online survey (Phase 1), forum discussion and statement development (Phase 2), and statement adjudication (Phase 3). Recent Findings In Phase 1 ( n = 100 clinicians), 12% routinely provided patients with ≥4 SABA prescriptions/year, 73% solicited SABA use frequency at every patient visit, and 21% did not consult asthma guidelines/expert reports. Phase 3 experts ( n = 8) reached consensus (median Likert sco... Mehr ...